Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease

Abstract

BackgroundHigh-throughput profiling of human tissues typically yield as results the gene lists comprised of a mix of relevant molecular entities with multiple false positives that obstruct the translation of such results into mechanistic hypotheses. From general probabilistic considerations, gene lists distilled for the mechanistically relevant components can be far more useful for subsequent experimental design or data interpretation.ResultsThe input candidate gene lists were processed into different tiers of evidence consistency established by enrichment analysis across subsets of the same experiments and across different experiments and platforms. The cut-offs were established empirically through ontological and semantic enrichment; resultant shortened gene list was re-expanded by Ingenuity Pathway Assistant tool. The resulting sub-networks provided the basis for generating mechanistic hypotheses that were partially validated by literature search. This approach differs from previous consistency-based studies in that the cut-off on the Receiver Operating Characteristic of the true-false separation process is optimized by flexible selection of the consistency building procedure. The gene list distilled by this analytic technique and its network representation were termed Compact Disease Model (CDM). Here we present the CDM signature for the study of early-stage Alzheimer’s disease. The integrated analysis of this gene signature allowed us to identify the protein traffic vesicles as prominent players in the pathogenesis of Alzheimer’s. Considering the distances and complexity of protein trafficking in neurons, it is plausible that spontaneous protein misfolding along with a shortage of growth stimulation result in neurodegeneration. Several potentially overlapping scenarios of early-stage Alzheimer pathogenesis have been discussed, with an emphasis on the protective effects of AT-1 mediated antihypertensive response on cytoskeleton remodeling, along with neuronal activation of oncogenes, luteinizing hormone signaling and insulin-related growth regulation, forming a pleiotropic model of its early stages. Alignment with emerging literature confirmed many predictions derived from early-stage Alzheimer’s disease’ CDM.ConclusionsA flexible approach for high-throughput data analysis, the Compact Disease Model generation, allows extraction of meaningful, mechanism-centered gene sets compatible with instant translation of the results into testable hypotheses.

Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH

“…Consistent with this hypothesis, a coexpression analysis of quantitative trait loci in AD brains revealed NHE6 as a top hub transcript, with 202 network connections and a plethora of potential downstream effects (12). A knowledge-based approach for predicting gene-disease associations also identified a link between NHE6 and early-stage AD (13). Stronger evidence emerged from a recent analysis of the metastable aggregation-prone proteome in AD brains that identified NHE6 as a key component of the proteostasis machinery associated with amyloid plaques and neurofibrillary tangles containing amyloid beta (Aβ) peptide and tau protein, respectively (14).…”

KPP: KEGG Pathway Painter

“…As microarrays became a common tool to decipher global gene expression, centralized systems like Gene Expression Omnibus (GEO), ArrayExpress was developed to congregate the valuable profile data [ 3 , 4 ]. An analysis of combined datasets generated in independent microarray experiments (so-called "microarray meta-analysis"), is often being employed [ 5 ], for example, to develop biomarker panels or to extract insights into the pathogenesis of various chronic diseases [ 6 ] including human malignancies [ 7 ]. Meta-analysis lead to an increase of the complexity in microarray analysis; therefore, sophistication of subsequent functional analysis also increased.…”

Predicting High-Impact Pharmacological Targets by Integrating Transcriptome and Text-Mining Features

“…The DEXCON feature reflects the stability of the differential expression signal in tumors of various tissue origins, and in the tumors of same origin. As it was shown earlier, the DEXCON score is superior to typical t-test based evaluations of the significance of observed differential expression patterns, as it takes into consideration a consistency of evidence (27). It is important to note that microarray-derived features are capable of serving as predictors even when completely novel target candidates comes into the scope of study; hence, their value is higher than that of text-mining features.…”